A Problem for Biotech | GenomeWeb

A Problem for Biotech

"Patent trolls" — companies that profit solely by legally enforcing patents they own — are beginning to target the biotech industry, and an August 31 ruling from a US federal court of appeals in Washington, DC, is making it easier for them to do, Nature News' Erika Check Hayden says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

At a Cost

Biotech Court

Duke's Troubles

Zika Beware

Not 'Just a Theory'

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.